European Pharmaceutical Review

SEPTEMBER 28, 2023

There has been a steady stream of developments in the vaccine manufacturing space throughout 2023. A notable milestone was Moderna’s announcement in April that it had, following finalisation of a ten-year strategic partnership with the UK Government, commenced construction of its mRNA vaccine manufacturing technology centre.

Manufacturing 81

Manufacturing Government Pharmaceutical manufacturing Pharmaceutical 81

pharmaphorum

OCTOBER 26, 2022

When people think about pharma, they often think about “big” pharma: large, faceless corporations. The status isn’t awarded lightly and Chiesi is the largest pharmaceutical manufacturer to be named a B Corp. “We But rare diseases are a particularly important and challenging focus area.

Patients 84

Patients Pharma Consulting Transportation 84

European Pharmaceutical Review

OCTOBER 12, 2023

September 2023 saw a wave of new pharmaceutical manufacturing facility expansions and launches across Europe. Research by the Confederation of British Industry (CBI) , released in September this year, highlighted progress for UK manufacturing in its latest Industrial Trends Survey. Kerry, Ireland.

Pharmaceutical manufacturing 82

Pharmaceutical manufacturing Manufacturing Pharmaceutical Pharma 82

European Pharmaceutical Review

JULY 21, 2023

Recommendations were also published earlier this year for all stakeholders in the pharma supply chain. In this Q&A EPR speaks to Naser Al Yammahi the Deputy CEO of Hayat Biotech about pharmaceutical supply chain challenges and how they can be addressed. Globalisation and supply chain complexity are a factor.

Pharmaceutical 93

Pharmaceutical Food and Drug Administration Transportation Manufacturing 93

Clarify Health

OCTOBER 26, 2021

In this blog, we take a close look at health equity in oncology trials specifically, assessing how the lack of diversity and inclusion has impacted cancer patients and the pharma industry’s key initiatives to address it. J National Comprehensive Cancer Network. 1] Zaorsky NG, Zhang Y, Walter V, Tchelebi LT, Chinchilli VM, Gusani NJ.

Food and Drug Administration 52

Food and Drug Administration Recruitment Pharmaceutical manufacturing Medical 52

pharmaphorum

DECEMBER 16, 2022

Compounding the situation to understand how such an outcome was allowed to occur is the fact that many deals between government and pharmaceutical companies selling the treatments and vaccines were agreed under terms of confidentiality.

Distribution 84

Distribution Pharmaceutical manufacturing Manufacturing Pharmaceutical 84

Pharmaceutical Technology

MARCH 22, 2023

In light of the Covid-19 pandemic, the war in Ukraine, and the Russian gas supply issue, several countries have called for onshoring, also referred to as reshoring; the bringing back of pharma production to locations within national borders to mitigate costs, supply issues, and concerns regarding bilateral relations.

Food and Drug Administration 105

Food and Drug Administration Manufacturing Government Pharmaceutical 105